Helping cancer patients quit smoking with a new treatment approach
Contingency Management to Promote Smoking Abstinence in Cancer Patients
This study tests a new way to help cancer patients quit smoking by combining a special treatment with their usual care to see if it works better than just standard methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 282 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT04605458 on ClinicalTrials.gov |
What this trial studies
This study aims to assist cancer patients in quitting smoking by providing a novel smoking cessation treatment alongside standard care, which includes counseling and nicotine patches. Participants diagnosed with or suspected of having operable cancer will be enrolled, and half will receive the new treatment while the other half will receive standard therapy. The goal is to evaluate the effectiveness of this contingency management approach in promoting smoking abstinence among this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 or older who smoke combustible tobacco products and have a diagnosis or suspicion of operable cancer.
Not a fit: Patients with unstable psychiatric or medical conditions, non-English speakers, or those using alternative nicotine delivery systems may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve smoking cessation rates among cancer patients, enhancing their overall health and recovery.
How similar studies have performed: Other studies have shown success with contingency management approaches in smoking cessation, indicating potential for positive outcomes in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 or older 2. smoking 1 or more combustible tobacco products per day 3. diagnosed with or suspicion of any type of operable cancer Exclusion Criteria: 1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia 2. non-English speaking 3. use of alternative nicotine delivery systems (e.g., e-cigarettes, snus, etc) 4. pregnant women
Where this trial is running
Charleston, South Carolina
- Medical University of South Carolina — Charleston, South Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Benjamin Toll — Medical University of South Carolina
- Study coordinator: Maddie Foster
- Email: fostemad@musc.edu
- Phone: 8437371516
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.